Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03209505 · ClinicalTrials.gov registry record · Phase 4
The Impact of Contact Lens Coefficient of Friction (CoF) on the Development of Lid Wiper Epitheliopathy (LWE)
A Phase 4 study, sponsored by University of Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT03209505 is a Phase 4 study that has completed, run by University of Houston. The registered enrollment target is 20 participants.
The verdict
NCT03209505, a Phase 4 study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study examines the development of Lid Wiper Epitheliopathy (LWE) in individuals fit with contact lenses having difference coefficients of friction (CoF)
Interventions
- DEVICE Acuvue Oasys
- DEVICE Air Optix Night & Day Aqua
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2018-04-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03209505
The ClinicalTrials.gov registry entry for NCT03209505 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Houston, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acuvue Oasys is the first listed.
NCT03209505 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03209505 about?
NCT03209505 is a clinical study titled "The Impact of Contact Lens Coefficient of Friction (CoF) on the Development of Lid Wiper Epitheliopathy (LWE)". This study examines the development of Lid Wiper Epitheliopathy (LWE) in individuals fit with contact lenses having difference coefficients of friction (CoF)
What is the current status of trial NCT03209505?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2017-06-26. Estimated completion is 2018-04-13.
What interventions are being tested in trial NCT03209505?
The interventions under investigation include: Acuvue Oasys (DEVICE), Air Optix Night & Day Aqua (DEVICE).
Who is sponsoring clinical trial NCT03209505?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.